Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations
Journal of Proteome Research · 2025
DOI: 10.1021/acs.jproteome.5c00088 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Panagiota S Filippou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biological Chemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biomarkers, Tumor, Proteomics, Proteome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 170 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biological Chemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- School of Medicine, Pharmacy & Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, U.K.
ORCID-Profile: Priyanka Dey
Zitieren
APA
Filippou, P. S., & Dey, P. (2025). Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00088
Vancouver
Filippou PS, Dey P. Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00088
BibTeX
@article{Filippou2025,
author = {Filippou, Panagiota S and Dey, Priyanka},
title = {Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations},
journal = {Journal of Proteome Research},
year = {2025},
doi = {10.1021/acs.jproteome.5c00088}
}
EUVIMED